P. Moos

发表

Topsentinol L Trisulfate, a new Marine Natural Product, that Targets Basal-like and Claudin-low Breast Cancers

Stephen R. Piccolo, M. K. Harper, Thomas E. Smith, 2020, bioRxiv.

Combating subclonal evolution of resistant cancer phenotypes

Brent S. Pedersen, Gabor Marth, Ryan M. Layer, 2017, Nature Communications.

Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy

Jeffrey T. Chang, Jason I. Griffiths, Lance T. Pflieger, 2020, bioRxiv.

Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy

Jeffrey T. Chang, Jason I. Griffiths, Lance T. Pflieger, 2020, Proceedings of the National Academy of Sciences.

Impact of Microarray Technology in Clinical Oncology

E. Raetz, P. Moos, 2004, Cancer investigation.

Genotoxicity of amorphous silica nanoparticles: Status and prospects.

P. Moos, M. Dobrovolskaia, H. Ghandehari, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Genomic classification of the RAS network identifies a personalized treatment strategy for lung cancer

Jeffrey T. Chang, Stephen R. Piccolo, Stephen R Piccolo, 2014, Molecular oncology.

Oxidation of 2-Cys-peroxiredoxins by Arachidonic Acid Peroxide Metabolites of Lipoxygenases and Cyclooxygenase-2*

F. Fitzpatrick, P. Moos, K. Edes, 2007, Journal of Biological Chemistry.

Purification and stability characterization of a cell regulatory sialoglgycopeptide inhibitor

P. Moos, T. Johnson, H. Fattaey, 1995, Journal of cellular biochemistry.

Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis.

F. Fitzpatrick, P. Moos, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1.

P. Moos, Colleen Rock, 2010, Prostaglandins, leukotrienes, and essential fatty acids.

Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility

Stephen R. Piccolo, W. Johnson, A. Bild, 2015, BMC Medical Genomics.

A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

Jeffrey T. Chang, Samuel W. Brady, M. Kahn, 2020, Translational oncology.

A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

Jeffrey T. Chang, Samuel W. Brady, M. Kahn, 2020, bioRxiv.

Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model

Lance T. Pflieger, A. Bild, A. Nath, 2020, Cancer Cell International.

Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction.

P. Moos, Robyn L. Poerschke, 2011, Biochemical pharmacology.

Curcumin impairs tumor suppressor p53 function in colon cancer cells.

F. Fitzpatrick, P. Moos, J. Mullally, 2004, Carcinogenesis.

Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid.

P. Moos, M. Franklin, Robyn L. Poerschke, 2008, Toxicology in vitro : an international journal published in association with BIBRA.

Selenium for the Prevention of Cutaneous Melanoma

H. Fain, P. Cassidy, S. Leachman, 2013, Nutrients.

Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase

P. Cassidy, F. Fitzpatrick, P. Moos, 2004, Journal of Biological Chemistry.

Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits.

F. Fitzpatrick, P. Moos, 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme.

F. Fitzpatrick, P. Moos, D. Muskardin, 1999, Journal of immunology.

Transcriptional responses of human aortic endothelial cells to nanoconstructs used in biomedical applications.

P. Moos, H. Ghandehari, A. Malugin, 2013, Molecular pharmaceutics.

Toxicogenomic Evaluation of Nanomaterials

S. Leachman, P. Moos, J. Veranth, 2013 .

Diversity of the apoptotic response to chemotherapy in childhood leukemia

S. Perkins, E. Raetz, P. Moos, 2002, Leukemia.

Cell proliferation inhibition in reduced gravity.

P. Moos, T. Johnson, H. Fattaey, 1994, Experimental cell research.

Prostaglandin H Synthase-2 Isoenzyme Expression in Macrophages : Induction of the Effect of Taxol and Taxotere on Gene

F. Fitzpatrick, P. Moos, D. Muskardin, 1998 .

Cyclooxygenase-2 induction by paclitaxel, docetaxel, and taxane analogues in human monocytes and murine macrophages: structure-activity relationships and their implications.

P. Cassidy, F. Fitzpatrick, P. Moos, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

MITF Is Regulated by Redox Signals Controlled by the Selenoprotein Thioredoxin Reductase 1

K. Wakamatsu, S. Ito, P. Cassidy, 2022, Cancers.

JS-K, a Nitric Oxide Prodrug, Has Enhanced Cytotoxicity in Colon Cancer Cells with Knockdown of Thioredoxin Reductase 1

P. Cassidy, P. Moos, P. Shami, 2010, PloS one.

Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.

P. Cassidy, K. Parsawar, F. Fitzpatrick, 2006, Carcinogenesis.

Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase*

P. Cassidy, F. Fitzpatrick, P. Moos, 2003, The Journal of Biological Chemistry.

Cyclopentenone Prostaglandins of the J Series Inhibit the Ubiquitin Isopeptidase Activity of the Proteasome Pathway*

F. Fitzpatrick, P. Moos, J. Mullally, 2001, The Journal of Biological Chemistry.

Identification of genes that are regulated transcriptionally by Myc in childhood tumors

R. Seeger, W. Carroll, E. Raetz, 2003, Cancer.

A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.

Andrew S. Dixon, Mohanad Mossalam, Abood Okal, 2013, Molecular pharmaceutics.

Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer

Jeffrey T. Chang, Lance T. Pflieger, N. Traficante, 2021, Nature Communications.

Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility

Stephen R. Piccolo, Irene L Andrulis, William Evan Johnson, 2016, Molecular systems biology.

Identification of gene expression profiles that segregate patients with childhood leukemia.

Aniko Szabo, Cheryl Willman, S. Hunger, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Title : Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility

I. Andrulis, P. Moos, 2015 .

Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins.

F. Fitzpatrick, P. Moos, K. Edes, 2000, Proceedings of the National Academy of Sciences of the United States of America.

GENE EXPRESSION PROFILING

W. Carroll, E. Raetz, P. Moos, 2001 .

Transient Receptor Potential Vanilloid 1 Agonists Cause Endoplasmic Reticulum Stress and Cell Death in Human Lung Cells

P. Moos, C. Reilly, G. Yost, 2007, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide

P. Moos, N. Betz, T. Johnson, 2004, Breast Cancer Research and Treatment.

Differential Gene Expression in Primary Human Skin Keratinocytes and Fibroblasts in Response to Ionizing Radiation

R. Warters, D. Gaffney, P. Moos, 2009, Radiation research.

A genomic approach to predict synergistic combinations for breast cancer treatment

Adam L Cohen, Luis Cheng, A. Bild, 2011, The Pharmacogenomics Journal.

The role of thioredoxin reductase 1 in melanoma metabolism and metastasis

P. Cassidy, S. Leachman, S. Florell, 2015, Pigment cell & melanoma research.

Selenoprotein P regulation by the glucocorticoid receptor

P. Moos, Colleen Rock, 2009, BioMetals.

Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes

A. Bild, P. Moos, M. Franklin, 2012, Journal of biochemical and molecular toxicology.

Differential gene expression patterns in vein regions susceptible versus resistant to neointimal hyperplasia.

D. Blumenthal, A. Cheung, Y. Shiu, 2018, Physiological genomics.

HIV-1 provirus transcription and translation in macrophages differs from pre-integrated cDNA complexes and requires E2F transcriptional programs

P. Moos, V. Planelles, L. Barrows, 2021, bioRxiv.

Running Title : Active HIV-1 replication favors E 2 F transcriptional programs

P. Moos, V. Planelles, L. Barrows, 2021 .

Pre- and post-initiation chemoprevention activity of 2-alkyl/aryl selenazolidine-4(R)-carboxylic acids against tobacco-derived nitrosamine (NNK)-induced lung tumors in the A/J mouse.

P. Moos, T. Aboul-Fadl, M. Franklin, 2007, Chemico-biological interactions.

ZnO particulate matter requires cell contact for toxicity in human colon cancer cells.

John M. Veranth, David Woessner, P. Moos, 2010, Chemical research in toxicology.

Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model

Lance T. Pflieger, A. Bild, A. Nath, 2020, Cancer Cell International.

Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model

Lance T. Pflieger, A. Bild, A. Nath, 2020, Cancer Cell International.

Time- and dose-dependent gene expression analysis of macrophage response as a function of porosity of silica nanoparticles.

P. Moos, H. Ghandehari, M. Yazdimamaghani, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity.

P. Moos, M. Honeggar, R. Beck, 2009, Toxicology and applied pharmacology.

Responses of human cells to ZnO nanoparticles: a gene transcription study.

David Woessner, P. Cassidy, S. Leachman, 2011, Metallomics : integrated biometal science.

Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles.

P. Moos, H. Ghandehari, M. Yazdimamaghani, 2018, Nanomedicine : nanotechnology, biology, and medicine.

Inhibition of TRPA1, Endoplasmic Reticulum Stress, Human Airway Epithelial Cell Damage, and Ectopic MUC5AC Expression by Vasaka (Adhatoda vasica; Malabar Nut) Tea

P. Moos, C. Reilly, T. Memon, 2023, Pharmaceuticals.

Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor

P. Moos, T. Johnson, Daniel J. Enebo, 1994, Journal of cellular biochemistry.

The identification of a naturally occurring cell surface growth inhibitor related to a previously described bovine sialoglycopeptide

P. Moos, T. Johnson, H. Fattaey, 1993, Journal of cellular biochemistry.

Identification of gene expression profiles that segregate patients with childhood leukemia.

S. Hunger, C. Willman, W. Carroll, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

The role of thioredoxin reductase 1 in melanoma metabolism and metastasis

P. Cassidy, S. Leachman, S. Florell, 2015, Pigment cell & melanoma research.

Thioredoxin reductase 1 knockdown disrupts pigment synthesis in melanocytes

P. Cassidy, S. Leachman, A. Indra, 2018, Free Radical Biology and Medicine.

Genomic classification of the RAS network identifies a personalized treatment strategy for lung cancer

Jeffrey T. Chang, Stephen R. Piccolo, A. Bild, 2014, Molecular oncology.